It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
….the Food and Drug Administration issued a new health alert requiring the drugs carry labels warning about confusion and memory loss, elevated blood sugar leading to Type 2 diabetes, and muscle weakness.
Not long ago, statins were jokingly promoted by some doctors with a “put them in the drinking water” argument. Physicians and drug company experts suggested that the ubiquitous cholesterol-lowering drugs -- including Lipitor, Mevacor, Crestor and Zocor -- should be sold over the counter like cold medications, or offered to everyone above a certain age. The medications appeared so beneficial to health and seemed so free of side effects.
….There is no question that statins -- the most profitable and among the most prescribed drugs ever -- have saved or prolonged millions of lives and will continue to do so. Most people at elevated risk for heart disease should be taking statins. The big issue now will center on determining whose risk is low to moderate and may not need medication.
The not-so-well-kept secret is that a daily dose of statin allows millions to eat whatever fatty food they like without worrying how it affects their cholesterol levels. That’s a tempting proposition. At the same time, drug companies find nothing more appealing than a pill that healthy people take daily for the rest of their lives. These two motivations combine to get million on statins who may not need them -- not much of a problem if there are no risks. But now we have evidence there is.
Among the PMDs are Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, transmissible spongiform encephalopathies (TSEs), serpin-deficiency disorders, hemolytic anemia, cystic fibrosis, diabetes type II, amyotrophic lateral sclerosis, secondary amyloidosis, dialysis-related amyloidosis and more than ten other rare diseases [2–5].